CIK 0001437402 · Large accelerated filer
ARDELYX, INC.
Sign in to watch- Ticker
- ARDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 510-745-7047
- Business address
- 34175 ARDENWOOD BLVD., FREMONT, CA, 94555
- Former names
- NTERYX INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $486,197
- in 8 filings
Net −$486,197. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- RAAB MICHAEL −$226K President & CEO sold 3% of stake
- Bishop John E −$76K See Remarks sold 6% of stake
- Brady James Parker −$58K Chief Human Resources Officer sold 6% of stake
- Williams Laura A −$41K Chief Patient Officer sold 3% of stake
- Foster Eric Duane −$33K Chief Commercial Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-21 | RAAB MICHAEL President & CEO | Sale | −15,009 | $3.86 | $58K | 1,663,357 |
| 2026-08-21 | RAAB MICHAEL President & CEO | Sale | −15,976 | $3.86 | $62K | 1,647,381 |
| 2026-08-21 | RAAB MICHAEL President & CEO | Sale | −8,411 | $3.86 | $32K | 1,638,970 |
| 2026-08-21 | RAAB MICHAEL President & CEO | Sale | −19,178 | $3.86 | $74K | 1,619,792 |
| 2026-07-15 | RAAB MICHAEL President & CEO | Option exercise 10b5-1 | +20,834 | $0.99 | $21K | 1,720,034 |
| 2026-07-15 | RAAB MICHAEL President & CEO | Sale 10b5-1 | −41,668 | $5.06 | $211K | 1,678,366 |
| 2026-07-15 | RAAB MICHAEL President & CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −20,834 | 290,834 | ||
| 2026-06-15 | RAAB MICHAEL President & CEO | Option exercise 10b5-1 | +20,833 | $0.99 | $21K | 1,740,866 |
| 2026-06-15 | RAAB MICHAEL President & CEO | Sale 10b5-1 | −41,666 | $5.67 | $236K | 1,699,200 |
| 2026-06-15 | RAAB MICHAEL President & CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −20,833 | 311,668 | ||
| 2026-05-21 | RAAB MICHAEL President & CEO | Sale | −14,933 | $6.27 | $94K | 1,759,848 |
| 2026-05-21 | RAAB MICHAEL President & CEO | Sale | −7,861 | $6.27 | $49K | 1,751,987 |
| 2026-05-21 | RAAB MICHAEL President & CEO | Sale | −17,926 | $6.27 | $112K | 1,734,061 |
| 2026-05-21 | RAAB MICHAEL President & CEO | Sale | −14,028 | $6.27 | $88K | 1,720,033 |
| 2026-05-15 | RAAB MICHAEL President & CEO | Option exercise 10b5-1 | +20,833 | $0.99 | $21K | 1,816,447 |
| 2026-05-15 | RAAB MICHAEL President & CEO | Sale 10b5-1 | −41,666 | $6.28 | $262K | 1,774,781 |
| 2026-05-15 | RAAB MICHAEL President & CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −20,833 | 332,501 | ||
| 2026-04-15 | RAAB MICHAEL President & CEO | Option exercise 10b5-1 | +20,834 | $0.99 | $21K | 1,837,282 |
| 2026-04-15 | RAAB MICHAEL President & CEO | Sale 10b5-1 | −41,668 | $6.29 | $262K | 1,795,614 |
| 2026-04-15 | RAAB MICHAEL President & CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −20,834 | 353,334 |
Page 1 of 3 · 57 trades